Jennifer Good

Jennifer Good

President and Chief Executive OfficeratTrevi Therapeutics· In proxies 2022–2025

Pay in FY2025+52% from the year before · Trevi Therapeutics stock +203.9% the same year

Jennifer Good was paid $3.9M in FY2025 (Dec), up 52%. Trevi Therapeutics stock rose 203.9% that year.

Pay$100 in the stock at the end of FY21 → $1.6K
Pay is from the Summary Compensation Table of each Trevi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Trevi TherapeuticsPublic company · 4 yr
    • President and Chief Executive Officer2022 – Present · 4 yrStock in role +1,784%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?